Cargando…
The First Year Experience of Newborn Screening for Pompe Disease in California
The California Department of Public Health started universal newborn screening for Pompe disease in August 2018 with a two-tier process including: (1) acid alpha-glucosidase (GAA) enzyme activity assay followed by, (2) GAA gene sequencing analysis. This study examines results from the first year of...
Autores principales: | Tang, Hao, Feuchtbaum, Lisa, Sciortino, Stanley, Matteson, Jamie, Mathur, Deepika, Bishop, Tracey, Olney, Richard S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422988/ https://www.ncbi.nlm.nih.gov/pubmed/33073007 http://dx.doi.org/10.3390/ijns6010009 |
Ejemplares similares
-
Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up
por: Matteson, Jamie, et al.
Publicado: (2021) -
The Clinical Impact of CLIR Tools toward Rapid Resolution of Post-Newborn Screening Confirmatory Testing for X-Linked Adrenoleukodystrophy in California
por: Tang, Hao, et al.
Publicado: (2020) -
Newborn Screening for Pompe Disease
por: Sawada, Takaaki, et al.
Publicado: (2020) -
Development of Newborn Screening for Pompe Disease
por: Hwu, Wuh-Liang, et al.
Publicado: (2020) -
Newborn Screening for Pompe Disease: Pennsylvania Experience
por: Ficicioglu, Can, et al.
Publicado: (2020)